Q32 Bio Inc.
Records under this name other than patents Q32 Bio Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,064,486 | Adeno-Associated Virus Compositions for Pah Gene Transfer and Methods of Use Thereof now held by City of Hope In force · Medium confidence | In force | Medium confidence | |
| US 11,053,305 | FUSION PROTEIN CONSTRUCTS COMPRISING ANTI-C3d ANTIBODY AND CR1 POLYPEPTIDE now held by Akebia Therapeutics, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 11,053,306 | FUSION PROTEIN CONSTRUCTS COMPRISING ANTI-C3d ANTIBODY AND FACTOR H now held by Akebia Therapeutics, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 11,879,008 | METHODS OF TREATING COMPLEMENT MEDIATED DISEASES WITH FUSION PROTEIN CONSTRUCTS COMPRISING ANTI-C3d ANTIBODY AND A COMPLEMENT MODULATOR now held by Akebia Therapeutics, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 11,952,585 | Methods of Treating Phenylketonuria now held by City of Hope In force · High confidence | In force | High confidence | |
| US 11,951,183 | Adeno-Associated Virus Compositions for Pah Gene Transfer and Methods of Use Thereof now held by City of Hope In force · Medium confidence | In force | Medium confidence | |
| US 12,076,420 | Adeno-Associated Virus Compositions for Restoring Pah Gene Function and Methods of Use Thereof now held by City of Hope In force · High confidence | In force | High confidence | |
| US 12,203,094 | Adeno-Associated Virus Compositions for Restoring Pah Gene Function and Methods of Use Thereof now held by City of Hope In force · Medium confidence | In force | Medium confidence | |
| 17/656,562 | Adeno-Associated Virus Compositions for Restoring Pah Gene Function and Methods of Use Thereof now held by City of Hope Abandoned Abandoned Nov 14, 2025 | Abandoned | Abandoned Nov 14, 2025 | |
| 18/542,100 | METHODS OF TREATING COMPLEMENT MEDIATED DISEASES WITH FUSION PROTEIN CONSTRUCTS COMPRISING ANTI-C3d ANTIBODY AND A COMPLEMENT MODULATOR now held by Akebia Therapeutics, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |